It is in my country. Advantage of having a comprehensive public health system that is free at the point of use. No health insurance providers involved.
Australia also has a NHS. But it leaves people without a choice as to a doctor and on a long waiting list for elective surgery. Private health insurance in my country is taken out by those who can afford it and want to have the doctor of their choice and treatment in a private hospital. This is a system that favors the rich. Low income earners and those on a government pension can't afford the high cost of private health insurance. Our public hospitals are over burdened and understaffed. The only upside is that the poor are never turned away in an emergency. No one has to sell their house to pay for drugs covered by the PBS and ambulances are free for pensioners.
£123 per unit for the NHS. Of course it costs, every unit has to be collected by trained staff, transported, tested for pathogens and then stored. These things all cost money.
I'll point out that the article you link to is from the US where the cost of medical care is silly, partly because hospitals up the costs because they know that they will usually end up dropping the price when the negotiations with the health insurance company start.
I think we all know about the inequality and corruption seen in the American health system.
Here is a link about the real cost to hospitals and their patients (not just money) receiving blood transfusions.
"BACKGROUND:
Red blood cell (RBC) transfusion is independently associated in a dose-dependent manner with increased intensive care unit stay, total hospital length of stay, and hospital-acquired complications. Since little is known of the cost of these transfusion-associated adverse outcomes our aim was to determine the total hospital cost associated with RBC transfusion and to assess any dose-dependent relationship.
STUDY DESIGN AND METHODS:
A retrospective cohort study of all multiday acute care inpatients discharged from a five hospital health service in Western Australia between July 2011 and June 2012 was conducted. Main outcome measures were incidence of RBC transfusion and mean inpatient hospital costs.
RESULTS:
Of 89,996 multiday, acute care inpatient discharges, 4805 (5.3%) were transfused at least 1 unit of RBCs. After potential confounders were adjusted for, the mean inpatient cost was 1.83 times higher in the transfused group compared with the nontransfused group (95% confidence interval, 1.78-1.89; p < 0.001). The estimated total hospital-associated cost of RBC transfusion in this study was AUD $77 million (US $72 million), representing 7.8% of total hospital expenditure on acute care inpatients. There was a significant dose-dependent association between the number of RBC units transfused and increased costs after adjusting for confounders.
CONCLUSION:
RBC transfusions were independently associated with significantly higher hospital costs. The financial implication to hospital budgets will assist in prioritizing areas to reduce the rate of RBC transfusions and in implementing patient blood management programs.
© 2014 AABB."
http://www.ncbi.nlm.nih.gov/pubmed/25488623
This is the hospitals' own survey data. Blood costs money, but the real cost is in patient outcomes. Complications from the use of blood mean longer hospital stays and increased costs. The figures don't lie. It will prove to be beneficial to hospitals, governments who subsidize medical practice, (as seen in countries with NHS systems) and patients who have better outcomes when blood is not used.